Publications

Home 9 Publication 9 CLINICAL TRIALS AND PUBLIC USE

CLINICAL TRIALS AND PUBLIC USE

April 26, 2001

Seventeenth Annual Joint Seminar Program: PATENT PRACTICE UPDATE (April 26, 2001)

Clinical drug trials bring new and more effective pharmacologic weapons to physicians almost on a daily basis. Most of these clinical studies that bring new drugs from bench to bedside are financed by pharmaceutical companies (sometimes referred to as Sponsors). Many of these drug trials are run by academic medical centers or by commercially oriented networks of contract-research organizations (CROs) and site-management organizations (SMOs). These clinical trials are generally governed by Master Clinical Research Agreements that the parties enter into. These agreements generally have strict confidentiality provisions.

Resources

clinical.pdf

Firm Highlights

The National Law Journal Shortlists Wiggin and Dana for Litigation Departments of the Year – White Collar

Wiggin and Dana is proud to announce that its White Collar Defense, Investigations, and Corporate Compliance Practice Group has been selected by The National Law Journal as a finalist for Litigation Departments of the Year, White Collar. The firm’s White Collar Defense, Investigations, and Corporate Compliance Practice Group includes former federal prosecutors from the U.S. […]

Benchmark Litigation Names Wiggin and Dana Partners to the 2025 “40 & Under List”

Wiggin and Dana Litigation Partners, Laura Ann K. Froning, Robyn E. Gallagher, and David Norman-Schiff were named to Benchmark Litigation’s 2025 “40 & Under List”. The Benchmark Litigation team bestows this distinction upon the nation’s most accomplished litigators aged 40 and younger who are considered the top emerging talent in litigation. The list is compiled based […]

Wiggin and Dana Expands Real Estate Practice with Addition of Vasiliki Yiannoulis-Riva

Wiggin and Dana LLP is pleased to announce that Vasiliki (Vasi) Yiannoulis-Riva has joined the firm as a Partner in the Real Estate, Environmental, Construction and Facilities Department, based in both the Stamford, CT and New York, NY offices. Vasi brings more than a decade of experience advising clients on commercial real estate transactions, leasing, […]

Chambers High Net Worth 2025 Honors Wiggin and Dana Lawyers and Private Client Services Practice

Wiggin and Dana is pleased to announce that the firm’s Private Client Services practice and its partners, Michael T. Clear, Daniel L. Daniels, Jevera K. Hennessey, Leonard Leader, Vanessa L. Maczko, Steven B. Malech, and Carolyn A. Reers, have been ranked in the ninth edition of the annual Chambers High Net Worth (HNW) 2025 Guide. Additionally, Jonathan […]

Wiggin and Dana Launches False Claims Act Defense and Compliance Practice Group

Wiggin and Dana is pleased to announce the launch of its new False Claims Act (FCA) Defense and Compliance Practice Group, created in response to a significant rise in FCA investigations and litigation. This new group unites the firm’s extensive experience on both sides of FCA matters—defense and prosecution—offering clients a comprehensive and strategic approach […]

Chambers USA 2025 Recognizes 23 Wiggin and Dana Lawyers Across 13 Practices in the USA-Nationwide and Connecticut Editions

Chambers USA 2025 has recognized 23 Wiggin and Dana attorneys across 13 practices. The firm was ranked Nationwide in Franchising, Outsourcing, International Trade, and Startups & Emerging Companies. Wiggin and Dana’s Litigation, White Collar, Health Care and Insurance groups were ranked in Band 1 in the Connecticut practice categories. The firm was also recognized and ranked […]